|
|
|
| home > pmps > autumn 2021 > maintaining cold chain integrity for pharmaceutical products |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The social and economic implications of the
COVID-19 pandemic have been felt on a global scale. As millions of
people were forced into lockdown, hundreds of thousands of businesses
stalled their operations, while healthcare systems were pushed to
breaking point. The COVID-19 pandemic has impacted practically every
aspect of our lives and it has also greatly influenced the cold chain
logistics industry. Pharmaceutical transport hasn’t stopped, but rather
increased as patients suffering from COVID-19 and other illnesses
required tests and medications delivered at their clinic or home with
the right temperaturecontrolled solutions. Of course, the scale,
criticality, and urgency underpinning the global COVID-19 vaccine
roll-out has presented a unique challenge itself. The pandemic has
brought many new challenges together with demanding requirements to the
cold chain logistics industry, such as:
- Ultra-low temperatures required for storage and transport of the mRNA vaccines
- Increased
importance of last mile delivery – direct to patient, direct to
hospital, and direct to vaccination centres. Getting medication safely
to patients by shipping directly to vaccination centres, pharmacies, and
patient’s homes, while ensuring that products are delivered at the
right time and temperature
- Increased demand for dry ice, while vaccine manufacturers raced to develop and distribute COVID-19 vaccines worldwide
- Increased
demand on road transportation in the EU. Due to the fact that the
COVID-19 vaccines have required a specific range of temperatures for
storage and transport – together with the demand for dry ice
applications, limited capacity in air cargo, and end-to-end visibility
requirements across the EU – almost 90% of COVID-19 vaccines are
delivered by road freight
- Importance of real-time monitoring to reduce the risk of damage, loss of quality, and wastage of the high value medical products
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Muge Suner is Senior Pharma Business, Key-Strategic Accounts Manager for Thermo King in Europe, Middle East, and Africa. Based in Brussels, Belgium, she has been leading the Thermo King PharmaSolutions operations since 2019. Following her studies at the Ankara University in Turkey she began and continued her career in major forwarding and supply chain companies such as Cosco, DB Schenker, and DHL, where she was responsible for account management for temperature controlled solutions in life sciences, healthcare, and pharma.
|
|
|
|
|
|
 |
News and Press Releases |
 |
Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed Using Nouscom’s Proprietary Viral Vector Platform
BASEL, Switzerland – 17th May 2022 - Nouscom, a clinical stage
immuno-oncology company developing both off-the-shelf and personalized
cancer neoantigen immunotherapies, today announced that Janssen Research
& Development, LLC (Janssen) received U.S. Food and Drug
Administration (FDA) clearance for its Investigational New Drug (IND)
candidate VAC85135, an off-the-shelf, viral vector-based cancer vaccine
for an oncologic indication. VAC85135 has been exclusively licensed to
Janssen.
More info >> |
|
 |
White Papers |
 |
|
Key to Outsourcing Method Development and Validation A Pragmatic Approach
RSSL
In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >> |
|
 |
Industry Events |
 |
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)
20-21 June 2022, Berlin, Germany
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is
held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers
pharmaceutical companies, CMOs and CDMOs, governmental bodies together
with pharmaceutical equipment providers and service companies to discuss
the manufacturing and packaging processes of the pharmaceutical
industry. Among the participating companies are Bayer, Sandoz, Merck,
Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >> |
|
|
